-+ 0.00%
-+ 0.00%
-+ 0.00%

Esperion Therapeutics shareholders approve 7 million-share increase to 2022 equity plan

PUBT·06/01/2026 20:23:42
Listen to the news
Esperion Therapeutics shareholders approve 7 million-share increase to 2022 equity plan
  • Esperion held its annual shareholder meeting on May 28, 2026.
  • Shareholders passed an amendment to the 2022 stock option and incentive plan, lifting the share pool by 7 million shares.
  • Shareholders backed an advisory resolution on executive pay.
  • Ernst & Young was ratified as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Esperion Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-039518), on June 01, 2026, and is solely responsible for the information contained therein.